{"gene":"ERCC4","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":1994,"finding":"XPA forms a ternary complex with the ERCC1/XPF (ERCC4) heterodimer; XPA affinity column retained ERCC1 and ERCC4(XPF) correcting activities from HeLa cell-free extract, establishing a direct protein-protein interaction between XPA and the ERCC1-XPF complex.","method":"XPA affinity column pulldown from HeLa cell-free extract; in vitro complementation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal functional complementation plus affinity pulldown, replicated conceptually in multiple subsequent studies","pmids":["8197175"],"is_preprint":false},{"year":1993,"finding":"ERCC1 co-purifies with XPF/ERCC4 as a ~100 kDa complex; extracts from ERCC1, ERCC4 (group 4), and XP-F cells all fail to complement each other in vitro, and depletion of ERCC1 simultaneously removes correcting activities for groups 4, 11, and XP-F, indicating ERCC1 and XPF form a functional repair complex.","method":"In vitro NER complementation assay; immunodepletion; native gel fractionation; immunoblotting","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical methods, independently confirmed by two labs in the same year (PMIDs 8253090 and 8253091)","pmids":["8253090","8253091"],"is_preprint":false},{"year":1995,"finding":"Purified XPF-ERCC1 heterodimer (ERCC1 38 kDa + XPF 112 kDa) from HeLa cells possesses endonuclease activity with preference for single-stranded DNA and bubble-structured duplex DNA; this activity is stimulated by RPA in the presence of UV-damaged DNA. XPF and ERCC4 are biochemically confirmed to be identical proteins.","method":"Purification from HeLa cells to homogeneity; endonuclease assay on model DNA substrates; in vitro NER complementation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical reconstitution with purified protein, multiple substrate assays","pmids":["7559382"],"is_preprint":false},{"year":1998,"finding":"Recombinant ERCC1-XPF purified from insect cells cleaves at single-strand/double-strand DNA junctions (5' side of junction) in the absence of other NER factors, requiring divalent cations (optimal at 0.2 mM Mn²⁺). A minimum of 4–8 unpaired nucleotides is required; the complex cuts splayed arm and flap substrates to remove 3' single-stranded arms, 2–8 nt from the junction.","method":"In vitro endonuclease assay with recombinant protein on defined DNA substrates; mutational analysis of substrate structure","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro with recombinant protein, systematic substrate structure-activity analysis","pmids":["9525876"],"is_preprint":false},{"year":1999,"finding":"In living CHO cells, GFP-tagged ERCC1/XPF moves freely through the nucleus (diffusion coefficient ~15 µm²/s) consistent with free complex rather than preassembled holocomplexes. UV-induced DNA damage causes transient, dose-dependent immobilization of ERCC1/XPF for ~4 minutes per repair event, consistent with distributive (not processive) participation in NER.","method":"GFP-tagging and live-cell fluorescence microscopy (FRAP) in CHO cells; UV irradiation","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct live-cell imaging with quantitative FRAP, functionally interpreted with mechanistic consequence","pmids":["10320375"],"is_preprint":false},{"year":2002,"finding":"The nuclease active site of the XPF-ERCC1 heterodimer resides within residues 670–740 of XPF. Point mutations of acidic and basic residues in this region abolish nuclease activity but not DNA binding, separating catalysis from substrate recognition. Seven residues are absolutely conserved with Mus81 and archaeal RNA helicase families, defining a shared nuclease motif.","method":"Affinity cleavage assay; site-directed mutagenesis; nuclease activity assays; DNA binding assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — active-site mutagenesis with separation-of-function demonstration, multiple mutants tested","pmids":["11953324"],"is_preprint":false},{"year":2004,"finding":"XPF-ERCC1 is required for repair of DNA double-strand breaks (DSBs) in mammals via a Ku86-independent end-joining mechanism. XPF-deficient fibroblasts are hypersensitive to γ-irradiation and accumulate persistent γH2AX foci; Ercc1−/− Ku86−/− cells show additive hypersensitivity and chromosomal aberrations; in vitro repair of DSBs with 3' overhangs produces large deletions in absence of ERCC1-XPF.","method":"Cell viability assay; γH2AX foci immunostaining; double-mutant mouse genetics (Ercc1−/− × Ku86−/−); in vitro DSB repair assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in mice plus in vitro reconstitution, multiple orthogonal readouts","pmids":["18541667"],"is_preprint":false},{"year":2004,"finding":"XPF physically interacts with hRad52 via the N-terminal domain of hRad52 and the XPF protein. This interaction is stable in human cell-free extracts and stimulates XPF-ERCC1 endonuclease activity while attenuating hRad52 strand annealing activity, placing XPF-ERCC1 in a ternary complex that processes recombination intermediates.","method":"Co-immunoprecipitation from cell-free extracts; direct protein interaction assay; endonuclease activity assay; strand annealing assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and functional assay in single lab, two orthogonal methods","pmids":["14734547"],"is_preprint":false},{"year":2005,"finding":"Crystal structure of ERCC1 central domain reveals it adopts a fold similar to archaeal Mus81/XPF nuclease domains despite low sequence identity; ERCC1 central domain and C-terminal HhH₂ domain both bind ssDNA. Crystal structure of the XPF-ERCC1 HhH₂ heterodimer reveals two independent ssDNA-binding surfaces. ERCC1 central domain preferentially binds 5' single-stranded overhangs at ssDNA/dsDNA junctions. A model is proposed in which XPF-ERCC1 recognizes branched DNA using HhH₂ domains of both subunits plus the ERCC1 central domain.","method":"X-ray crystallography; ssDNA binding assays; NER reconstitution with truncated XPF-ERCC1","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures of two domains combined with biochemical DNA binding validation","pmids":["16076955"],"is_preprint":false},{"year":2005,"finding":"Crystal structure of an archaeal XPF homodimer alone and bound to dsDNA reveals large domain movement upon DNA binding, coupling the (HhH)₂ domain and nuclease domain for recognition of ds/ssDNA junctions; two non-equivalent DNA-binding sites are identified, and a model is proposed in which XPF distorts a 3' flap substrate to engage both sites for cleavage.","method":"X-ray crystallography (apo and DNA-bound structures); structural comparison","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures of apo and DNA-bound forms with mechanistic interpretation","pmids":["15719018"],"is_preprint":false},{"year":2007,"finding":"ERCC1 directly binds XPA via a small region (peptide) of XPA with submicromolar affinity; crystal structure of ERCC1 in complex with an XPA peptide reveals the binding interface. This XPA peptide potently inhibits NER in cell-free assay, blocking excision of a cisplatin adduct, establishing that XPA-ERCC1 interaction is essential for ERCC1-XPF recruitment to NER complexes.","method":"X-ray crystallography of ERCC1-XPA peptide complex; surface plasmon resonance; cell-free NER inhibition assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus functional inhibition assay with defined peptide inhibitor","pmids":["17948053"],"is_preprint":false},{"year":2007,"finding":"ERCC1-XPF endonuclease is required for single-strand annealing (SSA) and also gene conversion in mammalian cells, supporting a role in synthesis-dependent strand annealing during DSB repair.","method":"Reporter gene assay for SSA and gene conversion; ERCC1-deficient cell lines; cell cycle arrest experiments","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined genetic readouts with repair-deficient cells, single lab","pmids":["17962301"],"is_preprint":false},{"year":2008,"finding":"ERCC1/XPF limits LINE-1 retrotransposition: XPF knockdown in human cells increases retrotransposition frequency, and ERCC1 complementation in ERCC1-deficient hamster cells reduces it, revealing that ERCC1-XPF processes flap intermediates generated during retrotransposon insertion.","method":"RNAi knockdown of XPF; genetic complementation in ERCC1-deficient cells; retrotransposition reporter assay","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function and gain-of-function experiments with defined phenotypic readout, single lab","pmids":["18396111"],"is_preprint":false},{"year":2008,"finding":"XPF controls TRF2 association with telomeric DNA and telomere length maintenance through two distinct mechanisms: (1) nuclease-activity-dependent control of TRF2 binding to telomeres; (2) nuclease-activity-independent regulation of telomere length. Overexpression of XPF induces telomere shortening in XPF-proficient cells; XPF complementation suppresses telomere lengthening in XPF-deficient cells.","method":"XPF overexpression and complementation; telomere length analysis; ChIP for TRF2; nuclease-dead XPF mutant","journal":"Mechanisms of ageing and development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — separation-of-function mutagenesis with two orthogonal readouts, single lab","pmids":["18812185"],"is_preprint":false},{"year":2009,"finding":"XPF-ERCC1 unhooking of ICLs is required for stable chromatin loading and FANCD2 foci formation at ICLs: in XPF-ERCC1-deficient cells, FANCD2 is monoubiquitinated but chromatin-bound FANCD2 levels are dramatically reduced and ICL-induced foci are significantly lower, establishing that ICL unhooking by XPF-ERCC1 is required for downstream FA pathway activation and homologous recombination.","method":"Chromatin fractionation; FANCD2 ubiquitination assay; immunofluorescence foci counting in XPF-deficient human, mouse, and hamster cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods across three species, genetic epistasis with clear pathway placement","pmids":["19805513"],"is_preprint":false},{"year":2010,"finding":"XPF protein stability depends on ERCC1: siRNA knockdown of ERCC1 significantly reduces XPF protein levels (but not mRNA), while ERCC1 knockdown by XPF does not reciprocally destabilize ERCC1, indicating XPF protein stability requires its heterodimer partner.","method":"RNAi knockdown; immunoblotting; RT-PCR for transcript levels","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, consistent finding across multiple cancer cell lines","pmids":["20418188"],"is_preprint":false},{"year":2010,"finding":"Missense mutations in XPF can cause cytoplasmic mislocalization of XPF-ERCC1: cells from XFE progeroid patients show XPF-ERCC1 accumulation in the cytoplasm. Microinjection of XPF(R153P)-ERCC1 into the nucleus of XPF-deficient human cells restores NER of UV damage, demonstrating that mislocalization (not catalytic inactivity) accounts for part of the DNA repair defect in XFE syndrome.","method":"Immunofluorescence; cell fractionation; YFP-tagged XPF live imaging; nuclear microinjection of recombinant protein; NER assay","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal localization methods plus functional rescue by nuclear microinjection","pmids":["20221251"],"is_preprint":false},{"year":2011,"finding":"SNM1A (hSNM1A) collaborates with XPF-ERCC1 to initiate ICL repair in replicating human cells: SNM1A 5'-3' exonuclease loads from XPF-ERCC1-induced nicks and digests past the ICL. Depletion of hSNM1A or ERCC1 each causes ICL sensitivity and accumulation of Mus81-dependent replication-associated DSBs.","method":"Purified protein biochemistry (exonuclease assay on ICL substrates); siRNA depletion; γH2AX foci; epistasis with Mus81","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified proteins plus cellular knockdown validation, single lab","pmids":["21896658"],"is_preprint":false},{"year":2012,"finding":"XPF (and XPG) endonuclease activity is required for CTCF-dependent chromatin looping between promoter and terminator of the RARβ2 gene: siRNA silencing or catalytic-site mutations in XPF prevent CTCF recruitment, chromatin loop formation, and optimal transcription, establishing a non-repair transcriptional role for XPF.","method":"RNAi; catalytic-site mutagenesis; chromosome conformation capture (3C); ChIP; transcription assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — catalytic-site mutagenesis separating repair from transcription function, multiple orthogonal assays","pmids":["22771116"],"is_preprint":false},{"year":2012,"finding":"Multiple DNA-binding domains of ERCC1-XPF cooperate for NER function: mutations in the HhH domain of ERCC1 or the nuclease domain of XPF abolish cleavage of model substrates. Mutations in multiple DNA-binding domains are required to significantly diminish NER activity in vitro and in vivo, and ICL repair requires tighter substrate binding than NER.","method":"Site-directed mutagenesis; in vitro NER reconstitution; cleavage assays on model substrates; cellular sensitivity to UV and MMC","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis with separation of NER vs ICL repair function, multiple orthogonal assays","pmids":["22547097"],"is_preprint":false},{"year":2012,"finding":"The XPF C-terminal HhH domain directly contacts ssDNA phosphate backbone (NMR structure); a guanine base is flipped into a pocket contacting residues from both HhH motifs; a one-residue deletion in XPF's second HhH motif permits ssDNA interactions distinct from ERCC1's dsDNA binding, establishing asymmetric DNA recognition by the XPF-ERCC1 heterodimer at ss/ds junctions.","method":"NMR structure determination of XPF HhH domain bound to ssDNA; comparison with ERCC1 structural data","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with detailed atomic contacts, single study","pmids":["22483113"],"is_preprint":false},{"year":2013,"finding":"Biallelic germline mutations in ERCC4 (XPF) cause Fanconi anemia (FA-Q subtype). FA-causing ERCC4 mutations strongly disrupt ICL repair function without severely compromising NER, demonstrating that ERCC4/XPF has separable NER and ICL repair activities, and that the type of mutation determines which disease (XP, XFE progeroid, or FA) manifests.","method":"Whole-exome and Sanger sequencing; genetic complementation with wild-type ERCC4 cDNA; cellular ICL and NER repair assays; chromosomal fragility assays","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic complementation proving causality, functional separation of ICL vs NER activities, multiple patient cell lines","pmids":["23623386"],"is_preprint":false},{"year":2014,"finding":"XPF-ERCC1 cooperates with SLX4/FANCP to carry out ICL unhooking incisions in replication-coupled ICL repair. Efficient recruitment of XPF-ERCC1 and SLX4 to the ICL requires FANCD2 and its ubiquitylation, establishing the pathway order: FANCD2 ubiquitylation → SLX4/XPF-ERCC1 recruitment → unhooking.","method":"Xenopus egg extract replication-coupled ICL repair assay; immunodepletion of XPF-ERCC1 and SLX4; FANCD2 ubiquitylation assay; DNA repair incision assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in Xenopus extracts with immunodepletion and epistasis, multiple mechanistic readouts","pmids":["24726325"],"is_preprint":false},{"year":2014,"finding":"USP45 deubiquitylase directly binds ERCC1 (via an acidic motif outside the USP45 catalytic domain), deubiquitylates ERCC1 in vitro, and promotes ERCC1-XPF translocation to UV-induced DNA damage foci. Loss of USP45 causes elevated ubiquitylated ERCC1, impaired ERCC1-XPF foci formation, and hypersensitivity to UV and ICL agents similar to ERCC1-deficient cells.","method":"Co-immunoprecipitation; in vitro deubiquitylation assay; USP45 knockout cells; UV sensitivity assay; immunofluorescence foci","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro deubiquitylation plus KO cell phenotype, multiple orthogonal methods, single lab","pmids":["25538220"],"is_preprint":false},{"year":2017,"finding":"RPA activates XPF-ERCC1 endonuclease activity at ICL-containing replication fork structures: a nascent leading strand inhibits XPF-ERCC1 incision on model fork substrates, but addition of RPA selectively restores activity. SNM1A can load from XPF-ERCC1-RPA-induced incisions and digest past the crosslink to complete unhooking.","method":"In vitro endonuclease assay with purified XPF-ERCC1, RPA, and defined ICL fork substrates; exonuclease loading assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro with purified components on defined substrates, mechanistic dissection of RPA role, single lab","pmids":["28607004"],"is_preprint":false},{"year":2017,"finding":"The helicase-like domain of XPF mediates binding to SLX4 for ICL-specific recruitment; a mutation in this domain disrupts SLX4 binding and recruitment to ICL but not to NER substrates. A second transient XPF-SLX4 interaction is required for positioning/unhooking. Nuclease domain mutations prevent incisions without affecting ICL localization, defining three separable steps: recruitment, positioning, and catalysis.","method":"Xenopus egg extract ICL and NER repair assays; site-directed mutagenesis; XPF localization to ICL by IP; separation-of-function mutants","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in Xenopus extracts with systematic structure-function mutagenesis, separation-of-function across three steps","pmids":["28292785"],"is_preprint":false},{"year":2017,"finding":"ERCC1-XPF cooperates with the insulator protein CTCF and cohesin (SMC1A, SMC3) to facilitate developmental silencing of imprinted genes. In vivo biotinylation tagging shows ERCC1-XPF co-localizes with CTCF, cohesin, MBD2, and ATRX at imprinted gene promoters and ICRs during postnatal hepatic development. Loss of Ercc1 dissociates CTCF-cohesin from promoters and alters histone marks without changing DNA methylation.","method":"In vivo biotinylation tagging in mice; mass spectrometry; ChIP; gene expression analysis; Ercc1 knockout mouse liver","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo tagging plus KO mice with multiple chromatin readouts, single lab but comprehensive","pmids":["28368372"],"is_preprint":false},{"year":2019,"finding":"SLX4IP binds both SLX4 and XPF-ERCC1 simultaneously, stabilizing the SLX4-XPF-ERCC1 complex; disruption of one interaction destabilizes both. SLX4IP depletion sensitizes cells to ICL agents and causes G2/M accumulation, promoting the interaction between SLX4 and XPF-ERCC1 particularly after DNA damage.","method":"Co-immunoprecipitation; GST pulldown; siRNA depletion; cell viability and cell cycle analysis; DNA damage induction","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and direct binding assays combined with knockdown phenotype, single lab","pmids":["31495888"],"is_preprint":false},{"year":2019,"finding":"ERCC1/XPF is required for repair of DSBs containing DNA secondary structures (AT-rich sequences from common fragile sites and G-quadruplexes). XPF inactivation is synthetically lethal with FANCM deficiency (which removes DNA secondary structures), and XPF sensitizes FANCM-deficient cells to G4-interacting compounds.","method":"CRISPR/siRNA-mediated XPF and FANCM inactivation; HR reporter assay; cytogenetic analysis; drug sensitivity assays","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with defined secondary structure substrates, single lab","pmids":["31153042"],"is_preprint":false},{"year":2020,"finding":"Cryo-EM structures of human XPF-ERCC1 reveal that the DNA-free form adopts an auto-inhibited conformation in which the XPF helical domain masks the ERCC1 (HhH)₂ domain and restricts access to the XPF catalytic site. DNA junction engagement releases this auto-inhibition, coupling ERCC1 (HhH)₂ with the nuclease domains. FA patient mutations in XPF are resistant to activation by the ICLR recruitment factor SLX4 despite retaining in vitro activity.","method":"Cryo-electron microscopy (DNA-free and DNA-bound); structure-function mutagenesis; SLX4-stimulated activation assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structures of two conformations with mutagenesis and functional validation, single study with multiple orthogonal approaches","pmids":["32111838"],"is_preprint":false},{"year":2017,"finding":"XPF protein requires heterodimerization with ERCC1 for nuclear import: in CRISPR/Cas9 XPF knockout cells, ERCC1 is retained in the cytoplasm and not detectable in the nucleus; overexpression of wild-type XPF restores ERCC1 nuclear localization, showing that XPF is required for nuclear entry of ERCC1.","method":"CRISPR/Cas9 XPF knockout; immunofluorescence; nuclear/cytoplasmic fractionation; XPF overexpression rescue","journal":"Cellular and molecular life sciences","confidence":"High","confidence_rationale":"Tier 2 / Moderate — complete genetic knockout with rescue experiment, two orthogonal localization methods","pmids":["28130555"],"is_preprint":false},{"year":2021,"finding":"The splicing factor XAB2 interacts with ERCC1-XPF (and XPG) outside of canonical NER; the trimeric XAB2-ERCC1-XPF-XPG complex binds RNA:DNA hybrids (R-loops). XAB2 depletion causes aberrant intron retention, R-loop formation, and DNA damage, linking spliceosomal function to R-loop processing by ERCC1-XPF.","method":"In vivo biotinylation tagging (IP-MS); immunoprecipitation; RNA:DNA hybrid binding assay; siRNA depletion; R-loop detection","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — IP-MS plus direct binding assay, single lab, novel non-canonical function","pmids":["34039990"],"is_preprint":false},{"year":2021,"finding":"In C. elegans, tissue-specific NER activity differs: in oocytes XPF-1 functions in global genome NER for rapid genome-wide lesion removal, whereas in post-mitotic neurons and muscles XPF-1 participates only in transcription-coupled NER of transcribed genes, establishing that XPF-1 NER subpathway usage is determined by cell type.","method":"In vivo imaging of tagged XPF-1 in C. elegans; tissue-specific NER analysis; loss-of-function genetics","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo imaging with functional readout in defined tissues, single model organism study","pmids":["33440146"],"is_preprint":false},{"year":2022,"finding":"XPF is recruited to ALT telomeres by telomeric RNA:DNA R-loops (TERRA R-loops) and induces DNA damage response (DDR) independently of CSB and SLX4, triggering break-induced telomere synthesis (ALT). XPF recruitment requires BRCA1 and RAD51 in FANCM-deficient cells that accumulate telomeric R-loops.","method":"TERRA depletion (RNA-targeting Cas9); TERRA interactome (mass spectrometry); XPF ChIP at telomeres; ALT-associated PML body analysis; telomere length assay; epistasis with CSB and SLX4","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods in single study, clear mechanistic pathway placement for novel XPF function","pmids":["36184605"],"is_preprint":false},{"year":2001,"finding":"Functional ERCC1-XPF heterodimer can be reconstituted from separately produced subunits (expressed in E. coli). ERCC1 alone can confer partial NER activity to ERCC1-deficient extracts only when endogenous XPF is present; adding ERCC1 to XPF-deficient extracts requires co-addition of XPF. Sequence comparison reveals similarity between ERCC1 and the C-terminal region of XPF, suggesting ancient gene duplication gave rise to both subunits.","method":"Recombinant protein expression in E. coli; NER complementation assay; immunoassays; protein sequence analysis","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — reconstitution from separately produced subunits with functional assay, single lab","pmids":["11160918"],"is_preprint":false},{"year":2015,"finding":"ERCC1-XPF participates in repair of Topoisomerase 1-attached nick DNA lesions (Tyr-nick DNA): ERCC1-XPF shows nuclease activity on Tyr-nick substrates in the presence of RPA in vitro; ERCC1-XPF and RPA co-localize in CPT-treated cells in vivo; repair synthesis of Tyr-nick DNA requires ERCC1-XPF, RPA, DNA polymerase delta, FEN1, and DNA ligase 1.","method":"In vitro nuclease assay on Tyr-nick substrates; EMSA; co-localization immunofluorescence; in vitro repair synthesis assay","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemistry plus cellular co-localization, single lab","pmids":["26025908"],"is_preprint":false},{"year":2018,"finding":"XP-causing XPF mutations (e.g. R799W) diminish XPF recruitment to DNA damage and mildly affect GG-NER, whereas an XPCS-complex-specific mutation causes persistent recruitment of XPF and upstream NER machinery to DNA damage, severely impairing both GG-NER and TC-NER. Persistent NER factor engagement at DNA damage is identified as a hallmark of XPCS-complex cells.","method":"Live-cell imaging of GFP-tagged XPF; FRAP; NER activity assays (host-cell reactivation, UDS); patient-derived cell lines","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — live-cell imaging combined with functional NER assays across multiple alleles, mechanistic separation of XP vs XPCS phenotypes","pmids":["30165384"],"is_preprint":false},{"year":2018,"finding":"XPF-ERCC1 mediates large deletions at DSBs associated with DNA:RNA hybrids (R-loops): XPF-dependent kilobase deletions are increased by Senataxin knockdown and reduced by RNaseH1 overexpression, and DNA:RNA hybrids are detected at DSB sites, establishing XPF as a mediator of mis-repair deletions at transcribed loci.","method":"Reporter gene deletion assay; Senataxin siRNA knockdown; RNaseH1 overexpression; DRIP (DNA:RNA immunoprecipitation); XPF knockdown","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic perturbations with defined molecular readout, single lab","pmids":["29497062"],"is_preprint":false},{"year":2018,"finding":"XPF and ARTEMIS independently cleave stalled DNA replication forks through non-epistatic pathways during S and G2 phases. Both nucleases are recruited to chromatin to promote replication fork restart; their rapid fork cleavage activity prevents mitotic segregation defects.","method":"Endonuclease knockdown/inhibition; chromosomal breakage analysis; cell cycle analysis; chromatin fractionation; genetic epistasis","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple molecular readouts, single lab","pmids":["30059501"],"is_preprint":false},{"year":2019,"finding":"TGFβ signaling enhances NER by increasing ERCC1-XPF and ERCC1-XPA protein interactions and promoting their nuclear co-localization; the effect requires intact TGFβ/Smad4 signaling and ERCC1, and is cell-cycle independent.","method":"Co-immunoprecipitation; immunofluorescence co-localization; siRNA of Smad4 and ERCC1; NER activity assays","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and co-localization with loss-of-function controls, single lab","pmids":["30418489"],"is_preprint":false}],"current_model":"ERCC4/XPF forms an obligate heterodimer with ERCC1, with XPF providing the nuclease active site (residues 670–740) and ERCC1 contributing DNA-binding and protein-interaction functions; the complex adopts an auto-inhibited conformation that is relieved upon engagement of branched DNA junctions, whereupon it cleaves the 5' side of the junction to execute the 5' incision in NER, ICL unhooking (facilitated by FANCD2-dependent recruitment of SLX4 and activated by RPA), DSB repair via end-joining and single-strand annealing, and additional roles in telomere maintenance, R-loop processing, transcriptional gene regulation via chromatin looping, and ALT-mediated telomere synthesis—with nuclear localization of the heterodimer requiring XPF, and ERCC1 stability in turn requiring XPF, while USP45-mediated deubiquitylation of ERCC1 promotes the complex's recruitment to DNA damage sites."},"narrative":{"mechanistic_narrative":"ERCC4 (XPF) is the catalytic subunit of a structure-specific endonuclease that operates as an obligate heterodimer with ERCC1 to incise DNA at single-strand/double-strand junctions across multiple genome-maintenance pathways [PMID:8253090, PMID:8253091, PMID:7559382, PMID:9525876]. The purified heterodimer cleaves bubble, splayed-arm, and flap substrates on the 5' side of ss/ds junctions, requiring divalent cations and a minimal stretch of unpaired nucleotides [PMID:9525876], with the nuclease active site mapping to XPF residues 670–740 where point mutations abolish catalysis without affecting DNA binding [PMID:11953324]. Structural work resolves the basis for substrate engagement: ERCC1 and XPF contribute non-equivalent (HhH)₂ and central domains that bind ssDNA and dsDNA asymmetrically [PMID:16076955, PMID:22483113], and cryo-EM shows the DNA-free complex adopts an auto-inhibited conformation that masks the active site until junction engagement couples the ERCC1 (HhH)₂ to the nuclease domains [PMID:32111838]. In nucleotide excision repair, the complex is recruited through direct ERCC1–XPA interaction to execute the 5' incision [PMID:8197175, PMID:17948053], and its participation is distributive, with damage-induced transient immobilization at lesions [PMID:10320375]. Beyond NER, XPF-ERCC1 carries out interstrand crosslink unhooking downstream of FANCD2 ubiquitylation and SLX4 recruitment, with RPA activating incision at replication-fork ICL structures and SNM1A loading from the resulting nicks [PMID:19805513, PMID:24726325, PMID:28607004, PMID:28292785], and it functions in double-strand break end-joining and single-strand annealing [PMID:18541667, PMID:17962301]. The complex additionally maintains telomeres [PMID:18812185], processes R-loops in association with XAB2 [PMID:34039990], drives ALT telomere synthesis via TERRA R-loops [PMID:36184605], and supports CTCF/cohesin-dependent chromatin looping for transcriptional regulation and imprinted-gene silencing independent of repair, a role requiring its catalytic activity [PMID:22771116, PMID:28368372]. Heterodimerization governs the complex's integrity and compartmentalization: XPF stability requires ERCC1 [PMID:20418188], nuclear import of ERCC1 requires XPF [PMID:28130555], and USP45-mediated deubiquitylation of ERCC1 promotes recruitment to damage sites [PMID:25538220]. Biallelic ERCC4 mutations cause Fanconi anemia, and the spectrum of XP, XFE progeroid, and FA phenotypes reflects mutations that separably impair NER, ICL repair, or proper localization [PMID:20221251, PMID:23623386, PMID:30165384].","teleology":[{"year":1993,"claim":"Established that ERCC4/XPF and ERCC1 are not independent repair factors but a single functional complex, unifying multiple complementation groups.","evidence":"In vitro NER complementation, immunodepletion, and native gel fractionation showing co-purification as a ~100 kDa complex","pmids":["8253090","8253091"],"confidence":"High","gaps":["Did not define the catalytic mechanism or substrate specificity","Stoichiometry and direct biochemical activity not yet characterized"]},{"year":1994,"claim":"Connected the ERCC1-XPF complex to the broader NER machinery by demonstrating a direct interaction with the damage-recognition factor XPA.","evidence":"XPA affinity column pulldown from HeLa extract plus in vitro complementation","pmids":["8197175"],"confidence":"High","gaps":["Did not map the interaction interface","Functional consequence of the interaction for incision not established"]},{"year":1995,"claim":"Showed the purified heterodimer is itself the endonuclease and is stimulated by RPA, identifying XPF and ERCC4 as the same protein.","evidence":"Purification to homogeneity from HeLa and endonuclease assays on model substrates","pmids":["7559382"],"confidence":"High","gaps":["Polarity and precise cleavage position not yet defined","Which subunit carries the active site unknown"]},{"year":1998,"claim":"Defined the structure-specific cleavage rule: incision on the 5' side of ss/ds junctions with a minimal unpaired-nucleotide requirement.","evidence":"Recombinant ERCC1-XPF endonuclease assays with systematic substrate variation and divalent cation requirements","pmids":["9525876"],"confidence":"High","gaps":["Active-site residues not yet localized","Did not address regulation in cells"]},{"year":2002,"claim":"Localized the nuclease active site to XPF residues 670–740 and separated catalysis from substrate binding.","evidence":"Affinity cleavage, site-directed mutagenesis, and parallel nuclease/DNA-binding assays","pmids":["11953324"],"confidence":"High","gaps":["Conformational regulation of the active site not addressed","Role of ERCC1 in catalysis not defined"]},{"year":1999,"claim":"Determined that the complex participates in NER distributively, transiently immobilizing at lesions rather than acting as a preassembled processive machine.","evidence":"Live-cell FRAP of GFP-tagged ERCC1/XPF in CHO cells after UV","pmids":["10320375"],"confidence":"High","gaps":["Molecular trigger of immobilization not defined","Did not address non-NER mobility behavior"]},{"year":2007,"claim":"Established at atomic resolution why the ERCC1-XPA interaction is essential for recruiting the complex to NER sites.","evidence":"Crystal structure of ERCC1-XPA peptide complex, SPR, and peptide-mediated cell-free NER inhibition","pmids":["17948053"],"confidence":"High","gaps":["Did not define recruitment dynamics in living cells","Interface relevance to ICL repair not addressed"]},{"year":2005,"claim":"Provided the structural basis for asymmetric branched-DNA recognition by the heterodimer's HhH and central domains.","evidence":"X-ray crystallography of ERCC1 domains and the XPF-ERCC1 (HhH)₂ heterodimer with ssDNA binding assays, plus archaeal XPF apo/DNA-bound structures","pmids":["16076955","15719018"],"confidence":"High","gaps":["Full-length complex architecture not resolved","Coupling between DNA binding and catalysis incompletely defined"]},{"year":2012,"claim":"Refined the DNA-recognition model with atomic XPF HhH-ssDNA contacts and demonstrated cooperative, multi-domain DNA binding governs NER versus ICL repair.","evidence":"NMR structure of XPF HhH bound to ssDNA and mutagenesis across multiple DNA-binding domains with NER/ICL functional readouts","pmids":["22483113","22547097"],"confidence":"High","gaps":["Did not capture the auto-inhibited full-length conformation","Quantitative affinity differences between pathways not fully mapped"]},{"year":2008,"claim":"Extended the complex's repertoire beyond NER to double-strand break end-joining, single-strand annealing, retrotransposition control, and telomere maintenance.","evidence":"Mouse double-mutant genetics and in vitro DSB repair; SSA/gene-conversion reporters; retrotransposition reporters; telomere length and TRF2 ChIP with nuclease-dead mutants","pmids":["18541667","17962301","18396111","18812185"],"confidence":"Medium","gaps":["Mechanistic step at which XPF acts in each pathway not fully defined","Nuclease-independent telomere role mechanism unresolved","Some readouts from single labs"]},{"year":2004,"claim":"Placed XPF-ERCC1 in recombination intermediate processing via direct interaction with hRad52.","evidence":"Co-IP from cell-free extracts plus endonuclease and strand-annealing activity assays","pmids":["14734547"],"confidence":"Medium","gaps":["Single lab without reciprocal in vivo validation","Physiological context of the ternary complex not established"]},{"year":2014,"claim":"Ordered the interstrand crosslink repair pathway: FANCD2 ubiquitylation licenses SLX4/XPF-ERCC1 recruitment for unhooking incisions, with FANCD2 foci themselves requiring upstream unhooking.","evidence":"Xenopus egg-extract replication-coupled ICL repair with immunodepletion and FANCD2 ubiquitylation/incision assays; chromatin fractionation and foci counting across species","pmids":["24726325","19805513"],"confidence":"High","gaps":["Did not define the conformational activation of the nuclease","Spatial positioning of incisions relative to the crosslink not fully resolved"]},{"year":2017,"claim":"Dissected ICL repair into separable recruitment, positioning, and catalysis steps and identified RPA and SNM1A as activators/partners of the incision reaction.","evidence":"Xenopus extract structure-function mutagenesis of XPF helicase-like and nuclease domains; in vitro RPA-activated incision and SNM1A loading on defined ICL fork substrates","pmids":["28292785","28607004","21896658"],"confidence":"High","gaps":["In vivo dynamics of the transient XPF-SLX4 interactions not visualized","Regulation of RPA-dependent activation in cells not established"]},{"year":2019,"claim":"Identified accessory factors and substrate contexts expanding XPF-ERCC1 function to secondary-structure DSBs and stabilization of the SLX4 complex.","evidence":"SLX4IP co-IP/GST pulldown with depletion phenotypes; CRISPR/siRNA XPF-FANCM synthetic lethality with HR reporters and G4 drug sensitivity","pmids":["31495888","31153042"],"confidence":"Medium","gaps":["Direct structural role of SLX4IP unresolved","Single-lab studies without orthogonal confirmation"]},{"year":2012,"claim":"Revealed a non-repair function in chromatin organization, showing XPF catalytic activity is required for CTCF-dependent chromatin looping and transcription, later extended to cohesin-dependent imprinted-gene silencing in vivo.","evidence":"3C, ChIP, and catalytic-site mutagenesis at RARβ2; in vivo biotinylation tagging, mass spectrometry, and Ercc1 knockout mouse liver chromatin analysis","pmids":["22771116","28368372"],"confidence":"High","gaps":["Substrate cleaved during looping not identified","Generality across other loci incompletely defined"]},{"year":2021,"claim":"Connected XPF-ERCC1 to R-loop biology through XAB2 association, ALT telomere synthesis, and mis-repair deletions at transcribed loci.","evidence":"IP-MS and RNA:DNA hybrid binding with XAB2; TERRA interactome, telomeric XPF ChIP, and ALT readouts; reporter deletion assays with Senataxin/RNaseH1 perturbation and DRIP","pmids":["34039990","36184605","29497062"],"confidence":"Medium","gaps":["Direct catalytic action on R-loops not biochemically reconstituted","Single-lab studies for several novel functions"]},{"year":2020,"claim":"Captured the regulatory switch of the complex: an auto-inhibited DNA-free conformation relieved by junction engagement, and showed FA mutations resist SLX4-dependent activation.","evidence":"Cryo-EM of DNA-free and DNA-bound human XPF-ERCC1 with mutagenesis and SLX4-stimulated activation assays","pmids":["32111838"],"confidence":"High","gaps":["Dynamics of the conformational transition in cells not measured","Activation by NER-specific factors not structurally resolved"]},{"year":2014,"claim":"Established that complex integrity and localization are regulated post-translationally and by heterodimerization, with disease mutations acting through mislocalization.","evidence":"USP45 deubiquitylation assays and KO phenotypes; XPF/ERCC1 reciprocal stability and nuclear-import dependence; XFE patient cell mislocalization with nuclear-microinjection rescue","pmids":["25538220","20418188","28130555","20221251"],"confidence":"High","gaps":["Ubiquitin ligase opposing USP45 not identified","Import machinery mediating XPF-dependent ERCC1 nuclear entry not defined"]},{"year":2021,"claim":"Demonstrated tissue- and pathway-specific deployment of XPF in NER, with cell type dictating global-genome versus transcription-coupled subpathway usage.","evidence":"In vivo imaging of tagged XPF-1 in C. elegans with tissue-specific NER and loss-of-function genetics","pmids":["33440146"],"confidence":"Medium","gaps":["Molecular determinant of subpathway choice not identified","Conservation of tissue specificity in mammals not established"]},{"year":null,"claim":"How the diverse non-canonical roles (chromatin looping, R-loop processing, ALT synthesis) are coordinated with classical repair, and what determines pathway choice at a given substrate, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking conformational activation to non-repair substrate engagement","Regulatory hierarchy among partners (SLX4, XAB2, CTCF, USP45) not integrated","Substrates cleaved during transcriptional/looping functions not biochemically defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[2,3,5]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[2,3,5]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[8,20,5]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[31,33]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,16,30]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[13,26,33]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[1,3,14,22]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[18,26]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[16,21,36]}],"complexes":["ERCC1-XPF heterodimer","SLX4-XPF-ERCC1 complex","XAB2-ERCC1-XPF-XPG complex"],"partners":["ERCC1","XPA","SLX4","RPA","USP45","SLX4IP","RAD52","XAB2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92889","full_name":"DNA repair endonuclease XPF","aliases":["DNA excision repair protein ERCC-4","DNA repair protein complementing XP-F cells","Xeroderma pigmentosum group F-complementing protein"],"length_aa":916,"mass_kda":104.5,"function":"Catalytic component of a structure-specific DNA repair endonuclease responsible for the 5-prime incision during DNA repair, and which is essential for nucleotide excision repair (NER) and interstrand cross-link (ICL) repair","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q92889/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ERCC4","classification":"Not Classified","n_dependent_lines":245,"n_total_lines":1208,"dependency_fraction":0.20281456953642385},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CDC7","stoichiometry":10.0},{"gene":"CDK7","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ERCC4","total_profiled":1310},"omim":[{"mim_id":"618439","title":"UBIQUITIN-SPECIFIC PROTEASE 45; USP45","url":"https://www.omim.org/entry/618439"},{"mim_id":"618038","title":"SHORTAGE IN CHIASMATA 1; SHOC1","url":"https://www.omim.org/entry/618038"},{"mim_id":"615823","title":"SLX1 HOMOLOG B, STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT; SLX1B","url":"https://www.omim.org/entry/615823"},{"mim_id":"615822","title":"SLX1 HOMOLOG A, STRUCTURE-SPECIFIC ENDONUCLEASE SUBUNIT; SLX1A","url":"https://www.omim.org/entry/615822"},{"mim_id":"615272","title":"FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ","url":"https://www.omim.org/entry/615272"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":17.1}],"url":"https://www.proteinatlas.org/search/ERCC4"},"hgnc":{"alias_symbol":["RAD1","FANCQ"],"prev_symbol":["XPF"]},"alphafold":{"accession":"Q92889","domains":[{"cath_id":"3.40.50.300","chopping":"18-207","consensus_level":"high","plddt":89.8205,"start":18,"end":207},{"cath_id":"3.40.50.300","chopping":"208-216_380-441_542-612","consensus_level":"medium","plddt":83.16,"start":208,"end":612},{"cath_id":"3.40.50.10130","chopping":"684-768_783-834","consensus_level":"high","plddt":85.4019,"start":684,"end":834},{"cath_id":"1.10.150.20","chopping":"847-914","consensus_level":"high","plddt":79.1941,"start":847,"end":914},{"cath_id":"1.20.1320","chopping":"221-349","consensus_level":"high","plddt":80.3042,"start":221,"end":349}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92889","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92889-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92889-F1-predicted_aligned_error_v6.png","plddt_mean":74.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ERCC4","jax_strain_url":"https://www.jax.org/strain/search?query=ERCC4"},"sequence":{"accession":"Q92889","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92889.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92889/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92889"}},"corpus_meta":[{"pmid":"10320375","id":"PMC_10320375","title":"Action of DNA repair endonuclease ERCC1/XPF in living cells.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10320375","citation_count":291,"is_preprint":false},{"pmid":"23623386","id":"PMC_23623386","title":"Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.","date":"2013","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23623386","citation_count":259,"is_preprint":false},{"pmid":"24726325","id":"PMC_24726325","title":"XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/24726325","citation_count":255,"is_preprint":false},{"pmid":"18541667","id":"PMC_18541667","title":"ERCC1-XPF endonuclease facilitates DNA double-strand break repair.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18541667","citation_count":246,"is_preprint":false},{"pmid":"18518821","id":"PMC_18518821","title":"Structural and functional relationships of the XPF/MUS81 family of proteins.","date":"2008","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18518821","citation_count":231,"is_preprint":false},{"pmid":"9525876","id":"PMC_9525876","title":"DNA structural elements required for ERCC1-XPF endonuclease activity.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9525876","citation_count":191,"is_preprint":false},{"pmid":"8197175","id":"PMC_8197175","title":"Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8197175","citation_count":183,"is_preprint":false},{"pmid":"11953324","id":"PMC_11953324","title":"The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11953324","citation_count":166,"is_preprint":false},{"pmid":"8253090","id":"PMC_8253090","title":"Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8253090","citation_count":160,"is_preprint":false},{"pmid":"22941649","id":"PMC_22941649","title":"DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22941649","citation_count":158,"is_preprint":false},{"pmid":"8253091","id":"PMC_8253091","title":"Evidence for a repair enzyme complex involving ERCC1 and complementing activities of ERCC4, ERCC11 and xeroderma pigmentosum group F.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8253091","citation_count":157,"is_preprint":false},{"pmid":"20418188","id":"PMC_20418188","title":"Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.","date":"2010","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/20418188","citation_count":144,"is_preprint":false},{"pmid":"16076955","id":"PMC_16076955","title":"Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16076955","citation_count":141,"is_preprint":false},{"pmid":"21612988","id":"PMC_21612988","title":"Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.","date":"2011","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/21612988","citation_count":135,"is_preprint":false},{"pmid":"17962301","id":"PMC_17962301","title":"The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cells.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17962301","citation_count":134,"is_preprint":false},{"pmid":"14729965","id":"PMC_14729965","title":"Growth retardation, early death, and DNA repair defects in mice deficient for the nucleotide excision repair enzyme XPF.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14729965","citation_count":132,"is_preprint":false},{"pmid":"20846399","id":"PMC_20846399","title":"Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.","date":"2010","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20846399","citation_count":130,"is_preprint":false},{"pmid":"17948053","id":"PMC_17948053","title":"Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17948053","citation_count":129,"is_preprint":false},{"pmid":"20944091","id":"PMC_20944091","title":"Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.","date":"2010","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20944091","citation_count":123,"is_preprint":false},{"pmid":"21896658","id":"PMC_21896658","title":"Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.","date":"2011","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/21896658","citation_count":122,"is_preprint":false},{"pmid":"19805513","id":"PMC_19805513","title":"XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19805513","citation_count":119,"is_preprint":false},{"pmid":"26074087","id":"PMC_26074087","title":"The ERCC1 and ERCC4 (XPF) genes and gene products.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26074087","citation_count":112,"is_preprint":false},{"pmid":"7559382","id":"PMC_7559382","title":"Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7559382","citation_count":112,"is_preprint":false},{"pmid":"8887684","id":"PMC_8887684","title":"ERCC4 (XPF) encodes a human nucleotide excision repair protein with eukaryotic recombination homologs.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8887684","citation_count":109,"is_preprint":false},{"pmid":"18192062","id":"PMC_18192062","title":"Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?","date":"2008","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/18192062","citation_count":94,"is_preprint":false},{"pmid":"15719018","id":"PMC_15719018","title":"Structure of an XPF endonuclease with and without DNA suggests a model for substrate recognition.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15719018","citation_count":93,"is_preprint":false},{"pmid":"22771116","id":"PMC_22771116","title":"XPG and XPF endonucleases trigger chromatin looping and DNA demethylation for accurate expression of activated genes.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22771116","citation_count":89,"is_preprint":false},{"pmid":"18396111","id":"PMC_18396111","title":"ERCC1/XPF limits L1 retrotransposition.","date":"2008","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18396111","citation_count":84,"is_preprint":false},{"pmid":"11160918","id":"PMC_11160918","title":"Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair.","date":"2001","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11160918","citation_count":84,"is_preprint":false},{"pmid":"14734547","id":"PMC_14734547","title":"Physical and functional interaction between the XPF/ERCC1 endonuclease and hRad52.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14734547","citation_count":83,"is_preprint":false},{"pmid":"19723666","id":"PMC_19723666","title":"Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19723666","citation_count":83,"is_preprint":false},{"pmid":"29544698","id":"PMC_29544698","title":"Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children.","date":"2018","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/29544698","citation_count":80,"is_preprint":false},{"pmid":"29440262","id":"PMC_29440262","title":"A meiotic XPF-ERCC1-like complex recognizes joint molecule recombination intermediates to promote crossover formation.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/29440262","citation_count":78,"is_preprint":false},{"pmid":"30563071","id":"PMC_30563071","title":"Function and Interactions of ERCC1-XPF in DNA Damage Response.","date":"2018","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/30563071","citation_count":73,"is_preprint":false},{"pmid":"23580445","id":"PMC_23580445","title":"Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cells.","date":"2013","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23580445","citation_count":69,"is_preprint":false},{"pmid":"12675797","id":"PMC_12675797","title":"An archaeal XPF repair endonuclease dependent on a heterotrimeric PCNA.","date":"2003","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12675797","citation_count":67,"is_preprint":false},{"pmid":"25956741","id":"PMC_25956741","title":"Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.","date":"2015","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/25956741","citation_count":64,"is_preprint":false},{"pmid":"20221251","id":"PMC_20221251","title":"Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20221251","citation_count":63,"is_preprint":false},{"pmid":"15944449","id":"PMC_15944449","title":"The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15944449","citation_count":60,"is_preprint":false},{"pmid":"24582975","id":"PMC_24582975","title":"Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24582975","citation_count":57,"is_preprint":false},{"pmid":"17118488","id":"PMC_17118488","title":"Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer.","date":"2006","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/17118488","citation_count":55,"is_preprint":false},{"pmid":"28607004","id":"PMC_28607004","title":"RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks.","date":"2017","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/28607004","citation_count":53,"is_preprint":false},{"pmid":"25538220","id":"PMC_25538220","title":"USP45 deubiquitylase controls ERCC1-XPF endonuclease-mediated DNA damage responses.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/25538220","citation_count":51,"is_preprint":false},{"pmid":"27650543","id":"PMC_27650543","title":"Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27650543","citation_count":50,"is_preprint":false},{"pmid":"18812185","id":"PMC_18812185","title":"Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms.","date":"2008","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/18812185","citation_count":48,"is_preprint":false},{"pmid":"34039990","id":"PMC_34039990","title":"The splicing factor XAB2 interacts with ERCC1-XPF and XPG for R-loop processing.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34039990","citation_count":47,"is_preprint":false},{"pmid":"16084390","id":"PMC_16084390","title":"Structural and functional analyses of an archaeal XPF/Rad1/Mus81 nuclease: asymmetric DNA binding and cleavage mechanisms.","date":"2005","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/16084390","citation_count":47,"is_preprint":false},{"pmid":"19763158","id":"PMC_19763158","title":"Xpf and not the Fanconi anaemia proteins or Rev3 accounts for the extreme resistance to cisplatin in Dictyostelium discoideum.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19763158","citation_count":47,"is_preprint":false},{"pmid":"29742103","id":"PMC_29742103","title":"SHOC1 is a ERCC4-(HhH)2-like protein, integral to the formation of crossover recombination intermediates during mammalian meiosis.","date":"2018","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29742103","citation_count":46,"is_preprint":false},{"pmid":"32111838","id":"PMC_32111838","title":"Cryo-EM structures of the XPF-ERCC1 endonuclease reveal how DNA-junction engagement disrupts an auto-inhibited conformation.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32111838","citation_count":45,"is_preprint":false},{"pmid":"8041709","id":"PMC_8041709","title":"Molecular cloning of the human nucleotide-excision-repair gene ERCC4.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8041709","citation_count":45,"is_preprint":false},{"pmid":"8960133","id":"PMC_8960133","title":"The importance of the ERCC1/ERCC4[XPF] complex for hypoxic-cell radioresistance does not appear to derive from its participation in the nucleotide excision repair pathway.","date":"1996","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/8960133","citation_count":44,"is_preprint":false},{"pmid":"28292785","id":"PMC_28292785","title":"Recruitment and positioning determine the specific role of the XPF-ERCC1 endonuclease in interstrand crosslink repair.","date":"2017","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/28292785","citation_count":44,"is_preprint":false},{"pmid":"21737503","id":"PMC_21737503","title":"XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.","date":"2011","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/21737503","citation_count":43,"is_preprint":false},{"pmid":"20658648","id":"PMC_20658648","title":"Multiple roles of ERCC1-XPF in mammalian interstrand crosslink repair.","date":"2010","source":"Environmental and molecular mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/20658648","citation_count":41,"is_preprint":false},{"pmid":"23166636","id":"PMC_23166636","title":"Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23166636","citation_count":41,"is_preprint":false},{"pmid":"21452186","id":"PMC_21452186","title":"Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity.","date":"2011","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/21452186","citation_count":39,"is_preprint":false},{"pmid":"15936543","id":"PMC_15936543","title":"Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants.","date":"2005","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/15936543","citation_count":38,"is_preprint":false},{"pmid":"21867914","id":"PMC_21867914","title":"XPF-dependent DNA breaks and RNA polymerase II arrest induced by antitumor DNA interstrand crosslinking-mimetic alkaloids.","date":"2011","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/21867914","citation_count":38,"is_preprint":false},{"pmid":"23435956","id":"PMC_23435956","title":"Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix.","date":"2013","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23435956","citation_count":36,"is_preprint":false},{"pmid":"15591065","id":"PMC_15591065","title":"An archaeal endonuclease displays key properties of both eukaryal XPF-ERCC1 and Mus81.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15591065","citation_count":36,"is_preprint":false},{"pmid":"10479728","id":"PMC_10479728","title":"Polymorphisms in the human DNA repair gene XPF.","date":"1999","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/10479728","citation_count":36,"is_preprint":false},{"pmid":"31153042","id":"PMC_31153042","title":"ERCC1/XPF Is Important for Repair of DNA Double-Strand Breaks Containing Secondary Structures.","date":"2019","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/31153042","citation_count":35,"is_preprint":false},{"pmid":"33931939","id":"PMC_33931939","title":"The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer.","date":"2021","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33931939","citation_count":35,"is_preprint":false},{"pmid":"30797591","id":"PMC_30797591","title":"ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.","date":"2019","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30797591","citation_count":35,"is_preprint":false},{"pmid":"22768293","id":"PMC_22768293","title":"Association between XPF polymorphisms and cancer risk: a meta-analysis.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22768293","citation_count":33,"is_preprint":false},{"pmid":"22547097","id":"PMC_22547097","title":"Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22547097","citation_count":33,"is_preprint":false},{"pmid":"21672525","id":"PMC_21672525","title":"MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21672525","citation_count":33,"is_preprint":false},{"pmid":"33440146","id":"PMC_33440146","title":"Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33440146","citation_count":32,"is_preprint":false},{"pmid":"23909490","id":"PMC_23909490","title":"Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.","date":"2013","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/23909490","citation_count":32,"is_preprint":false},{"pmid":"31495888","id":"PMC_31495888","title":"SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31495888","citation_count":31,"is_preprint":false},{"pmid":"7596355","id":"PMC_7596355","title":"Partial characterization of the DNA repair protein complex, containing the ERCC1, ERCC4, ERCC11 and XPF correcting activities.","date":"1995","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7596355","citation_count":30,"is_preprint":false},{"pmid":"30535472","id":"PMC_30535472","title":"miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/30535472","citation_count":30,"is_preprint":false},{"pmid":"30854110","id":"PMC_30854110","title":"MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.","date":"2019","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30854110","citation_count":30,"is_preprint":false},{"pmid":"28368372","id":"PMC_28368372","title":"ERCC1-XPF cooperates with CTCF and cohesin to facilitate the developmental silencing of imprinted genes.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28368372","citation_count":30,"is_preprint":false},{"pmid":"24027083","id":"PMC_24027083","title":"Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles.","date":"2013","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/24027083","citation_count":29,"is_preprint":false},{"pmid":"8332082","id":"PMC_8332082","title":"Regional mapping of human DNA excision repair gene ERCC4 to chromosome 16p13.13-p13.2.","date":"1993","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/8332082","citation_count":29,"is_preprint":false},{"pmid":"30165384","id":"PMC_30165384","title":"Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30165384","citation_count":29,"is_preprint":false},{"pmid":"30566683","id":"PMC_30566683","title":"The conserved XPF:ERCC1-like Zip2:Spo16 complex controls meiotic crossover formation through structure-specific DNA binding.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/30566683","citation_count":29,"is_preprint":false},{"pmid":"22186232","id":"PMC_22186232","title":"Formaldehyde-induced genome instability is suppressed by an XPF-dependent pathway.","date":"2011","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/22186232","citation_count":28,"is_preprint":false},{"pmid":"30059501","id":"PMC_30059501","title":"DNA replication stress triggers rapid DNA replication fork breakage by Artemis and XPF.","date":"2018","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30059501","citation_count":27,"is_preprint":false},{"pmid":"23576554","id":"PMC_23576554","title":"Structure-specific endonucleases xpf and mus81 play overlapping but essential roles in DNA repair by homologous recombination.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/23576554","citation_count":27,"is_preprint":false},{"pmid":"31369707","id":"PMC_31369707","title":"Targeting DNA Repair in Tumor Cells via Inhibition of ERCC1-XPF.","date":"2019","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31369707","citation_count":25,"is_preprint":false},{"pmid":"26025908","id":"PMC_26025908","title":"Repair synthesis step involving ERCC1-XPF participates in DNA repair of the Top1-DNA damage complex.","date":"2015","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/26025908","citation_count":25,"is_preprint":false},{"pmid":"22848636","id":"PMC_22848636","title":"Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22848636","citation_count":25,"is_preprint":false},{"pmid":"21424776","id":"PMC_21424776","title":"Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.","date":"2011","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/21424776","citation_count":25,"is_preprint":false},{"pmid":"29497062","id":"PMC_29497062","title":"Large XPF-dependent deletions following misrepair of a DNA double strand break are prevented by the RNA:DNA helicase Senataxin.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29497062","citation_count":25,"is_preprint":false},{"pmid":"11095693","id":"PMC_11095693","title":"Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts.","date":"2000","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11095693","citation_count":25,"is_preprint":false},{"pmid":"8660947","id":"PMC_8660947","title":"Roles of XPG and XPF/ERCC1 endonucleases in UV-induced immunostaining of PCNA in fibroblasts.","date":"1996","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/8660947","citation_count":24,"is_preprint":false},{"pmid":"29105242","id":"PMC_29105242","title":"ERCC4 variants identified in a cohort of patients with segmental progeroid syndromes.","date":"2017","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/29105242","citation_count":23,"is_preprint":false},{"pmid":"31891209","id":"PMC_31891209","title":"Computer-aided drug design of small molecule inhibitors of the ERCC1-XPF protein-protein interaction.","date":"2020","source":"Chemical biology & drug design","url":"https://pubmed.ncbi.nlm.nih.gov/31891209","citation_count":23,"is_preprint":false},{"pmid":"22483113","id":"PMC_22483113","title":"The structure of the XPF-ssDNA complex underscores the distinct roles of the XPF and ERCC1 helix- hairpin-helix domains in ss/ds DNA recognition.","date":"2012","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/22483113","citation_count":23,"is_preprint":false},{"pmid":"32271760","id":"PMC_32271760","title":"XPF-ERCC1 protects liver, kidney and blood homeostasis outside the canonical excision repair pathways.","date":"2020","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32271760","citation_count":22,"is_preprint":false},{"pmid":"36184605","id":"PMC_36184605","title":"XPF activates break-induced telomere synthesis.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36184605","citation_count":21,"is_preprint":false},{"pmid":"16584298","id":"PMC_16584298","title":"Involvement of ERCC1/XPF and XPG in oligodeoxynucleotide-directed gene modification.","date":"2006","source":"Oligonucleotides","url":"https://pubmed.ncbi.nlm.nih.gov/16584298","citation_count":21,"is_preprint":false},{"pmid":"21423097","id":"PMC_21423097","title":"Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking- and drinking-dependent larynx cancer in a Polish population.","date":"2011","source":"Experimental oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21423097","citation_count":20,"is_preprint":false},{"pmid":"30418489","id":"PMC_30418489","title":"TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.","date":"2019","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/30418489","citation_count":19,"is_preprint":false},{"pmid":"27542841","id":"PMC_27542841","title":"Higher expression of XPF is a critical factor in intrinsic chemotherapy resistance of human renal cell carcinoma.","date":"2016","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27542841","citation_count":19,"is_preprint":false},{"pmid":"28130555","id":"PMC_28130555","title":"XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.","date":"2017","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/28130555","citation_count":19,"is_preprint":false},{"pmid":"20008103","id":"PMC_20008103","title":"PCNA and XPF cooperate to distort DNA substrates.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20008103","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46559,"output_tokens":9971,"usd":0.144621,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20228,"output_tokens":5803,"usd":0.123107,"stage2_stop_reason":"end_turn"},"total_usd":0.267728,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"XPA forms a ternary complex with the ERCC1/XPF (ERCC4) heterodimer; XPA affinity column retained ERCC1 and ERCC4(XPF) correcting activities from HeLa cell-free extract, establishing a direct protein-protein interaction between XPA and the ERCC1-XPF complex.\",\n      \"method\": \"XPA affinity column pulldown from HeLa cell-free extract; in vitro complementation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal functional complementation plus affinity pulldown, replicated conceptually in multiple subsequent studies\",\n      \"pmids\": [\"8197175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"ERCC1 co-purifies with XPF/ERCC4 as a ~100 kDa complex; extracts from ERCC1, ERCC4 (group 4), and XP-F cells all fail to complement each other in vitro, and depletion of ERCC1 simultaneously removes correcting activities for groups 4, 11, and XP-F, indicating ERCC1 and XPF form a functional repair complex.\",\n      \"method\": \"In vitro NER complementation assay; immunodepletion; native gel fractionation; immunoblotting\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical methods, independently confirmed by two labs in the same year (PMIDs 8253090 and 8253091)\",\n      \"pmids\": [\"8253090\", \"8253091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Purified XPF-ERCC1 heterodimer (ERCC1 38 kDa + XPF 112 kDa) from HeLa cells possesses endonuclease activity with preference for single-stranded DNA and bubble-structured duplex DNA; this activity is stimulated by RPA in the presence of UV-damaged DNA. XPF and ERCC4 are biochemically confirmed to be identical proteins.\",\n      \"method\": \"Purification from HeLa cells to homogeneity; endonuclease assay on model DNA substrates; in vitro NER complementation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical reconstitution with purified protein, multiple substrate assays\",\n      \"pmids\": [\"7559382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Recombinant ERCC1-XPF purified from insect cells cleaves at single-strand/double-strand DNA junctions (5' side of junction) in the absence of other NER factors, requiring divalent cations (optimal at 0.2 mM Mn²⁺). A minimum of 4–8 unpaired nucleotides is required; the complex cuts splayed arm and flap substrates to remove 3' single-stranded arms, 2–8 nt from the junction.\",\n      \"method\": \"In vitro endonuclease assay with recombinant protein on defined DNA substrates; mutational analysis of substrate structure\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro with recombinant protein, systematic substrate structure-activity analysis\",\n      \"pmids\": [\"9525876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"In living CHO cells, GFP-tagged ERCC1/XPF moves freely through the nucleus (diffusion coefficient ~15 µm²/s) consistent with free complex rather than preassembled holocomplexes. UV-induced DNA damage causes transient, dose-dependent immobilization of ERCC1/XPF for ~4 minutes per repair event, consistent with distributive (not processive) participation in NER.\",\n      \"method\": \"GFP-tagging and live-cell fluorescence microscopy (FRAP) in CHO cells; UV irradiation\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct live-cell imaging with quantitative FRAP, functionally interpreted with mechanistic consequence\",\n      \"pmids\": [\"10320375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The nuclease active site of the XPF-ERCC1 heterodimer resides within residues 670–740 of XPF. Point mutations of acidic and basic residues in this region abolish nuclease activity but not DNA binding, separating catalysis from substrate recognition. Seven residues are absolutely conserved with Mus81 and archaeal RNA helicase families, defining a shared nuclease motif.\",\n      \"method\": \"Affinity cleavage assay; site-directed mutagenesis; nuclease activity assays; DNA binding assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — active-site mutagenesis with separation-of-function demonstration, multiple mutants tested\",\n      \"pmids\": [\"11953324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"XPF-ERCC1 is required for repair of DNA double-strand breaks (DSBs) in mammals via a Ku86-independent end-joining mechanism. XPF-deficient fibroblasts are hypersensitive to γ-irradiation and accumulate persistent γH2AX foci; Ercc1−/− Ku86−/− cells show additive hypersensitivity and chromosomal aberrations; in vitro repair of DSBs with 3' overhangs produces large deletions in absence of ERCC1-XPF.\",\n      \"method\": \"Cell viability assay; γH2AX foci immunostaining; double-mutant mouse genetics (Ercc1−/− × Ku86−/−); in vitro DSB repair assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in mice plus in vitro reconstitution, multiple orthogonal readouts\",\n      \"pmids\": [\"18541667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"XPF physically interacts with hRad52 via the N-terminal domain of hRad52 and the XPF protein. This interaction is stable in human cell-free extracts and stimulates XPF-ERCC1 endonuclease activity while attenuating hRad52 strand annealing activity, placing XPF-ERCC1 in a ternary complex that processes recombination intermediates.\",\n      \"method\": \"Co-immunoprecipitation from cell-free extracts; direct protein interaction assay; endonuclease activity assay; strand annealing assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and functional assay in single lab, two orthogonal methods\",\n      \"pmids\": [\"14734547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structure of ERCC1 central domain reveals it adopts a fold similar to archaeal Mus81/XPF nuclease domains despite low sequence identity; ERCC1 central domain and C-terminal HhH₂ domain both bind ssDNA. Crystal structure of the XPF-ERCC1 HhH₂ heterodimer reveals two independent ssDNA-binding surfaces. ERCC1 central domain preferentially binds 5' single-stranded overhangs at ssDNA/dsDNA junctions. A model is proposed in which XPF-ERCC1 recognizes branched DNA using HhH₂ domains of both subunits plus the ERCC1 central domain.\",\n      \"method\": \"X-ray crystallography; ssDNA binding assays; NER reconstitution with truncated XPF-ERCC1\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures of two domains combined with biochemical DNA binding validation\",\n      \"pmids\": [\"16076955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structure of an archaeal XPF homodimer alone and bound to dsDNA reveals large domain movement upon DNA binding, coupling the (HhH)₂ domain and nuclease domain for recognition of ds/ssDNA junctions; two non-equivalent DNA-binding sites are identified, and a model is proposed in which XPF distorts a 3' flap substrate to engage both sites for cleavage.\",\n      \"method\": \"X-ray crystallography (apo and DNA-bound structures); structural comparison\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures of apo and DNA-bound forms with mechanistic interpretation\",\n      \"pmids\": [\"15719018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ERCC1 directly binds XPA via a small region (peptide) of XPA with submicromolar affinity; crystal structure of ERCC1 in complex with an XPA peptide reveals the binding interface. This XPA peptide potently inhibits NER in cell-free assay, blocking excision of a cisplatin adduct, establishing that XPA-ERCC1 interaction is essential for ERCC1-XPF recruitment to NER complexes.\",\n      \"method\": \"X-ray crystallography of ERCC1-XPA peptide complex; surface plasmon resonance; cell-free NER inhibition assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus functional inhibition assay with defined peptide inhibitor\",\n      \"pmids\": [\"17948053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ERCC1-XPF endonuclease is required for single-strand annealing (SSA) and also gene conversion in mammalian cells, supporting a role in synthesis-dependent strand annealing during DSB repair.\",\n      \"method\": \"Reporter gene assay for SSA and gene conversion; ERCC1-deficient cell lines; cell cycle arrest experiments\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined genetic readouts with repair-deficient cells, single lab\",\n      \"pmids\": [\"17962301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ERCC1/XPF limits LINE-1 retrotransposition: XPF knockdown in human cells increases retrotransposition frequency, and ERCC1 complementation in ERCC1-deficient hamster cells reduces it, revealing that ERCC1-XPF processes flap intermediates generated during retrotransposon insertion.\",\n      \"method\": \"RNAi knockdown of XPF; genetic complementation in ERCC1-deficient cells; retrotransposition reporter assay\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function and gain-of-function experiments with defined phenotypic readout, single lab\",\n      \"pmids\": [\"18396111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"XPF controls TRF2 association with telomeric DNA and telomere length maintenance through two distinct mechanisms: (1) nuclease-activity-dependent control of TRF2 binding to telomeres; (2) nuclease-activity-independent regulation of telomere length. Overexpression of XPF induces telomere shortening in XPF-proficient cells; XPF complementation suppresses telomere lengthening in XPF-deficient cells.\",\n      \"method\": \"XPF overexpression and complementation; telomere length analysis; ChIP for TRF2; nuclease-dead XPF mutant\",\n      \"journal\": \"Mechanisms of ageing and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — separation-of-function mutagenesis with two orthogonal readouts, single lab\",\n      \"pmids\": [\"18812185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"XPF-ERCC1 unhooking of ICLs is required for stable chromatin loading and FANCD2 foci formation at ICLs: in XPF-ERCC1-deficient cells, FANCD2 is monoubiquitinated but chromatin-bound FANCD2 levels are dramatically reduced and ICL-induced foci are significantly lower, establishing that ICL unhooking by XPF-ERCC1 is required for downstream FA pathway activation and homologous recombination.\",\n      \"method\": \"Chromatin fractionation; FANCD2 ubiquitination assay; immunofluorescence foci counting in XPF-deficient human, mouse, and hamster cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods across three species, genetic epistasis with clear pathway placement\",\n      \"pmids\": [\"19805513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"XPF protein stability depends on ERCC1: siRNA knockdown of ERCC1 significantly reduces XPF protein levels (but not mRNA), while ERCC1 knockdown by XPF does not reciprocally destabilize ERCC1, indicating XPF protein stability requires its heterodimer partner.\",\n      \"method\": \"RNAi knockdown; immunoblotting; RT-PCR for transcript levels\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, consistent finding across multiple cancer cell lines\",\n      \"pmids\": [\"20418188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Missense mutations in XPF can cause cytoplasmic mislocalization of XPF-ERCC1: cells from XFE progeroid patients show XPF-ERCC1 accumulation in the cytoplasm. Microinjection of XPF(R153P)-ERCC1 into the nucleus of XPF-deficient human cells restores NER of UV damage, demonstrating that mislocalization (not catalytic inactivity) accounts for part of the DNA repair defect in XFE syndrome.\",\n      \"method\": \"Immunofluorescence; cell fractionation; YFP-tagged XPF live imaging; nuclear microinjection of recombinant protein; NER assay\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal localization methods plus functional rescue by nuclear microinjection\",\n      \"pmids\": [\"20221251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SNM1A (hSNM1A) collaborates with XPF-ERCC1 to initiate ICL repair in replicating human cells: SNM1A 5'-3' exonuclease loads from XPF-ERCC1-induced nicks and digests past the ICL. Depletion of hSNM1A or ERCC1 each causes ICL sensitivity and accumulation of Mus81-dependent replication-associated DSBs.\",\n      \"method\": \"Purified protein biochemistry (exonuclease assay on ICL substrates); siRNA depletion; γH2AX foci; epistasis with Mus81\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified proteins plus cellular knockdown validation, single lab\",\n      \"pmids\": [\"21896658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"XPF (and XPG) endonuclease activity is required for CTCF-dependent chromatin looping between promoter and terminator of the RARβ2 gene: siRNA silencing or catalytic-site mutations in XPF prevent CTCF recruitment, chromatin loop formation, and optimal transcription, establishing a non-repair transcriptional role for XPF.\",\n      \"method\": \"RNAi; catalytic-site mutagenesis; chromosome conformation capture (3C); ChIP; transcription assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — catalytic-site mutagenesis separating repair from transcription function, multiple orthogonal assays\",\n      \"pmids\": [\"22771116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Multiple DNA-binding domains of ERCC1-XPF cooperate for NER function: mutations in the HhH domain of ERCC1 or the nuclease domain of XPF abolish cleavage of model substrates. Mutations in multiple DNA-binding domains are required to significantly diminish NER activity in vitro and in vivo, and ICL repair requires tighter substrate binding than NER.\",\n      \"method\": \"Site-directed mutagenesis; in vitro NER reconstitution; cleavage assays on model substrates; cellular sensitivity to UV and MMC\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with separation of NER vs ICL repair function, multiple orthogonal assays\",\n      \"pmids\": [\"22547097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The XPF C-terminal HhH domain directly contacts ssDNA phosphate backbone (NMR structure); a guanine base is flipped into a pocket contacting residues from both HhH motifs; a one-residue deletion in XPF's second HhH motif permits ssDNA interactions distinct from ERCC1's dsDNA binding, establishing asymmetric DNA recognition by the XPF-ERCC1 heterodimer at ss/ds junctions.\",\n      \"method\": \"NMR structure determination of XPF HhH domain bound to ssDNA; comparison with ERCC1 structural data\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with detailed atomic contacts, single study\",\n      \"pmids\": [\"22483113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Biallelic germline mutations in ERCC4 (XPF) cause Fanconi anemia (FA-Q subtype). FA-causing ERCC4 mutations strongly disrupt ICL repair function without severely compromising NER, demonstrating that ERCC4/XPF has separable NER and ICL repair activities, and that the type of mutation determines which disease (XP, XFE progeroid, or FA) manifests.\",\n      \"method\": \"Whole-exome and Sanger sequencing; genetic complementation with wild-type ERCC4 cDNA; cellular ICL and NER repair assays; chromosomal fragility assays\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic complementation proving causality, functional separation of ICL vs NER activities, multiple patient cell lines\",\n      \"pmids\": [\"23623386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"XPF-ERCC1 cooperates with SLX4/FANCP to carry out ICL unhooking incisions in replication-coupled ICL repair. Efficient recruitment of XPF-ERCC1 and SLX4 to the ICL requires FANCD2 and its ubiquitylation, establishing the pathway order: FANCD2 ubiquitylation → SLX4/XPF-ERCC1 recruitment → unhooking.\",\n      \"method\": \"Xenopus egg extract replication-coupled ICL repair assay; immunodepletion of XPF-ERCC1 and SLX4; FANCD2 ubiquitylation assay; DNA repair incision assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in Xenopus extracts with immunodepletion and epistasis, multiple mechanistic readouts\",\n      \"pmids\": [\"24726325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"USP45 deubiquitylase directly binds ERCC1 (via an acidic motif outside the USP45 catalytic domain), deubiquitylates ERCC1 in vitro, and promotes ERCC1-XPF translocation to UV-induced DNA damage foci. Loss of USP45 causes elevated ubiquitylated ERCC1, impaired ERCC1-XPF foci formation, and hypersensitivity to UV and ICL agents similar to ERCC1-deficient cells.\",\n      \"method\": \"Co-immunoprecipitation; in vitro deubiquitylation assay; USP45 knockout cells; UV sensitivity assay; immunofluorescence foci\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro deubiquitylation plus KO cell phenotype, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"25538220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RPA activates XPF-ERCC1 endonuclease activity at ICL-containing replication fork structures: a nascent leading strand inhibits XPF-ERCC1 incision on model fork substrates, but addition of RPA selectively restores activity. SNM1A can load from XPF-ERCC1-RPA-induced incisions and digest past the crosslink to complete unhooking.\",\n      \"method\": \"In vitro endonuclease assay with purified XPF-ERCC1, RPA, and defined ICL fork substrates; exonuclease loading assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro with purified components on defined substrates, mechanistic dissection of RPA role, single lab\",\n      \"pmids\": [\"28607004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The helicase-like domain of XPF mediates binding to SLX4 for ICL-specific recruitment; a mutation in this domain disrupts SLX4 binding and recruitment to ICL but not to NER substrates. A second transient XPF-SLX4 interaction is required for positioning/unhooking. Nuclease domain mutations prevent incisions without affecting ICL localization, defining three separable steps: recruitment, positioning, and catalysis.\",\n      \"method\": \"Xenopus egg extract ICL and NER repair assays; site-directed mutagenesis; XPF localization to ICL by IP; separation-of-function mutants\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in Xenopus extracts with systematic structure-function mutagenesis, separation-of-function across three steps\",\n      \"pmids\": [\"28292785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ERCC1-XPF cooperates with the insulator protein CTCF and cohesin (SMC1A, SMC3) to facilitate developmental silencing of imprinted genes. In vivo biotinylation tagging shows ERCC1-XPF co-localizes with CTCF, cohesin, MBD2, and ATRX at imprinted gene promoters and ICRs during postnatal hepatic development. Loss of Ercc1 dissociates CTCF-cohesin from promoters and alters histone marks without changing DNA methylation.\",\n      \"method\": \"In vivo biotinylation tagging in mice; mass spectrometry; ChIP; gene expression analysis; Ercc1 knockout mouse liver\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo tagging plus KO mice with multiple chromatin readouts, single lab but comprehensive\",\n      \"pmids\": [\"28368372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SLX4IP binds both SLX4 and XPF-ERCC1 simultaneously, stabilizing the SLX4-XPF-ERCC1 complex; disruption of one interaction destabilizes both. SLX4IP depletion sensitizes cells to ICL agents and causes G2/M accumulation, promoting the interaction between SLX4 and XPF-ERCC1 particularly after DNA damage.\",\n      \"method\": \"Co-immunoprecipitation; GST pulldown; siRNA depletion; cell viability and cell cycle analysis; DNA damage induction\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and direct binding assays combined with knockdown phenotype, single lab\",\n      \"pmids\": [\"31495888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ERCC1/XPF is required for repair of DSBs containing DNA secondary structures (AT-rich sequences from common fragile sites and G-quadruplexes). XPF inactivation is synthetically lethal with FANCM deficiency (which removes DNA secondary structures), and XPF sensitizes FANCM-deficient cells to G4-interacting compounds.\",\n      \"method\": \"CRISPR/siRNA-mediated XPF and FANCM inactivation; HR reporter assay; cytogenetic analysis; drug sensitivity assays\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with defined secondary structure substrates, single lab\",\n      \"pmids\": [\"31153042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cryo-EM structures of human XPF-ERCC1 reveal that the DNA-free form adopts an auto-inhibited conformation in which the XPF helical domain masks the ERCC1 (HhH)₂ domain and restricts access to the XPF catalytic site. DNA junction engagement releases this auto-inhibition, coupling ERCC1 (HhH)₂ with the nuclease domains. FA patient mutations in XPF are resistant to activation by the ICLR recruitment factor SLX4 despite retaining in vitro activity.\",\n      \"method\": \"Cryo-electron microscopy (DNA-free and DNA-bound); structure-function mutagenesis; SLX4-stimulated activation assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structures of two conformations with mutagenesis and functional validation, single study with multiple orthogonal approaches\",\n      \"pmids\": [\"32111838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"XPF protein requires heterodimerization with ERCC1 for nuclear import: in CRISPR/Cas9 XPF knockout cells, ERCC1 is retained in the cytoplasm and not detectable in the nucleus; overexpression of wild-type XPF restores ERCC1 nuclear localization, showing that XPF is required for nuclear entry of ERCC1.\",\n      \"method\": \"CRISPR/Cas9 XPF knockout; immunofluorescence; nuclear/cytoplasmic fractionation; XPF overexpression rescue\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complete genetic knockout with rescue experiment, two orthogonal localization methods\",\n      \"pmids\": [\"28130555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The splicing factor XAB2 interacts with ERCC1-XPF (and XPG) outside of canonical NER; the trimeric XAB2-ERCC1-XPF-XPG complex binds RNA:DNA hybrids (R-loops). XAB2 depletion causes aberrant intron retention, R-loop formation, and DNA damage, linking spliceosomal function to R-loop processing by ERCC1-XPF.\",\n      \"method\": \"In vivo biotinylation tagging (IP-MS); immunoprecipitation; RNA:DNA hybrid binding assay; siRNA depletion; R-loop detection\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — IP-MS plus direct binding assay, single lab, novel non-canonical function\",\n      \"pmids\": [\"34039990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In C. elegans, tissue-specific NER activity differs: in oocytes XPF-1 functions in global genome NER for rapid genome-wide lesion removal, whereas in post-mitotic neurons and muscles XPF-1 participates only in transcription-coupled NER of transcribed genes, establishing that XPF-1 NER subpathway usage is determined by cell type.\",\n      \"method\": \"In vivo imaging of tagged XPF-1 in C. elegans; tissue-specific NER analysis; loss-of-function genetics\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo imaging with functional readout in defined tissues, single model organism study\",\n      \"pmids\": [\"33440146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"XPF is recruited to ALT telomeres by telomeric RNA:DNA R-loops (TERRA R-loops) and induces DNA damage response (DDR) independently of CSB and SLX4, triggering break-induced telomere synthesis (ALT). XPF recruitment requires BRCA1 and RAD51 in FANCM-deficient cells that accumulate telomeric R-loops.\",\n      \"method\": \"TERRA depletion (RNA-targeting Cas9); TERRA interactome (mass spectrometry); XPF ChIP at telomeres; ALT-associated PML body analysis; telomere length assay; epistasis with CSB and SLX4\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods in single study, clear mechanistic pathway placement for novel XPF function\",\n      \"pmids\": [\"36184605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Functional ERCC1-XPF heterodimer can be reconstituted from separately produced subunits (expressed in E. coli). ERCC1 alone can confer partial NER activity to ERCC1-deficient extracts only when endogenous XPF is present; adding ERCC1 to XPF-deficient extracts requires co-addition of XPF. Sequence comparison reveals similarity between ERCC1 and the C-terminal region of XPF, suggesting ancient gene duplication gave rise to both subunits.\",\n      \"method\": \"Recombinant protein expression in E. coli; NER complementation assay; immunoassays; protein sequence analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution from separately produced subunits with functional assay, single lab\",\n      \"pmids\": [\"11160918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ERCC1-XPF participates in repair of Topoisomerase 1-attached nick DNA lesions (Tyr-nick DNA): ERCC1-XPF shows nuclease activity on Tyr-nick substrates in the presence of RPA in vitro; ERCC1-XPF and RPA co-localize in CPT-treated cells in vivo; repair synthesis of Tyr-nick DNA requires ERCC1-XPF, RPA, DNA polymerase delta, FEN1, and DNA ligase 1.\",\n      \"method\": \"In vitro nuclease assay on Tyr-nick substrates; EMSA; co-localization immunofluorescence; in vitro repair synthesis assay\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemistry plus cellular co-localization, single lab\",\n      \"pmids\": [\"26025908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"XP-causing XPF mutations (e.g. R799W) diminish XPF recruitment to DNA damage and mildly affect GG-NER, whereas an XPCS-complex-specific mutation causes persistent recruitment of XPF and upstream NER machinery to DNA damage, severely impairing both GG-NER and TC-NER. Persistent NER factor engagement at DNA damage is identified as a hallmark of XPCS-complex cells.\",\n      \"method\": \"Live-cell imaging of GFP-tagged XPF; FRAP; NER activity assays (host-cell reactivation, UDS); patient-derived cell lines\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live-cell imaging combined with functional NER assays across multiple alleles, mechanistic separation of XP vs XPCS phenotypes\",\n      \"pmids\": [\"30165384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"XPF-ERCC1 mediates large deletions at DSBs associated with DNA:RNA hybrids (R-loops): XPF-dependent kilobase deletions are increased by Senataxin knockdown and reduced by RNaseH1 overexpression, and DNA:RNA hybrids are detected at DSB sites, establishing XPF as a mediator of mis-repair deletions at transcribed loci.\",\n      \"method\": \"Reporter gene deletion assay; Senataxin siRNA knockdown; RNaseH1 overexpression; DRIP (DNA:RNA immunoprecipitation); XPF knockdown\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic perturbations with defined molecular readout, single lab\",\n      \"pmids\": [\"29497062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"XPF and ARTEMIS independently cleave stalled DNA replication forks through non-epistatic pathways during S and G2 phases. Both nucleases are recruited to chromatin to promote replication fork restart; their rapid fork cleavage activity prevents mitotic segregation defects.\",\n      \"method\": \"Endonuclease knockdown/inhibition; chromosomal breakage analysis; cell cycle analysis; chromatin fractionation; genetic epistasis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple molecular readouts, single lab\",\n      \"pmids\": [\"30059501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TGFβ signaling enhances NER by increasing ERCC1-XPF and ERCC1-XPA protein interactions and promoting their nuclear co-localization; the effect requires intact TGFβ/Smad4 signaling and ERCC1, and is cell-cycle independent.\",\n      \"method\": \"Co-immunoprecipitation; immunofluorescence co-localization; siRNA of Smad4 and ERCC1; NER activity assays\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and co-localization with loss-of-function controls, single lab\",\n      \"pmids\": [\"30418489\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ERCC4/XPF forms an obligate heterodimer with ERCC1, with XPF providing the nuclease active site (residues 670–740) and ERCC1 contributing DNA-binding and protein-interaction functions; the complex adopts an auto-inhibited conformation that is relieved upon engagement of branched DNA junctions, whereupon it cleaves the 5' side of the junction to execute the 5' incision in NER, ICL unhooking (facilitated by FANCD2-dependent recruitment of SLX4 and activated by RPA), DSB repair via end-joining and single-strand annealing, and additional roles in telomere maintenance, R-loop processing, transcriptional gene regulation via chromatin looping, and ALT-mediated telomere synthesis—with nuclear localization of the heterodimer requiring XPF, and ERCC1 stability in turn requiring XPF, while USP45-mediated deubiquitylation of ERCC1 promotes the complex's recruitment to DNA damage sites.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ERCC4 (XPF) is the catalytic subunit of a structure-specific endonuclease that operates as an obligate heterodimer with ERCC1 to incise DNA at single-strand/double-strand junctions across multiple genome-maintenance pathways [#1, #2, #3]. The purified heterodimer cleaves bubble, splayed-arm, and flap substrates on the 5' side of ss/ds junctions, requiring divalent cations and a minimal stretch of unpaired nucleotides [#3], with the nuclease active site mapping to XPF residues 670\\u2013740 where point mutations abolish catalysis without affecting DNA binding [#5]. Structural work resolves the basis for substrate engagement: ERCC1 and XPF contribute non-equivalent (HhH)\\u2082 and central domains that bind ssDNA and dsDNA asymmetrically [#8, #20], and cryo-EM shows the DNA-free complex adopts an auto-inhibited conformation that masks the active site until junction engagement couples the ERCC1 (HhH)\\u2082 to the nuclease domains [#29]. In nucleotide excision repair, the complex is recruited through direct ERCC1\\u2013XPA interaction to execute the 5' incision [#0, #10], and its participation is distributive, with damage-induced transient immobilization at lesions [#4]. Beyond NER, XPF-ERCC1 carries out interstrand crosslink unhooking downstream of FANCD2 ubiquitylation and SLX4 recruitment, with RPA activating incision at replication-fork ICL structures and SNM1A loading from the resulting nicks [#14, #22, #24, #25], and it functions in double-strand break end-joining and single-strand annealing [#6, #11]. The complex additionally maintains telomeres [#13], processes R-loops in association with XAB2 [#31], drives ALT telomere synthesis via TERRA R-loops [#33], and supports CTCF/cohesin-dependent chromatin looping for transcriptional regulation and imprinted-gene silencing independent of repair, a role requiring its catalytic activity [#18, #26]. Heterodimerization governs the complex's integrity and compartmentalization: XPF stability requires ERCC1 [#15], nuclear import of ERCC1 requires XPF [#30], and USP45-mediated deubiquitylation of ERCC1 promotes recruitment to damage sites [#23]. Biallelic ERCC4 mutations cause Fanconi anemia, and the spectrum of XP, XFE progeroid, and FA phenotypes reflects mutations that separably impair NER, ICL repair, or proper localization [#16, #21, #36].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established that ERCC4/XPF and ERCC1 are not independent repair factors but a single functional complex, unifying multiple complementation groups.\",\n      \"evidence\": \"In vitro NER complementation, immunodepletion, and native gel fractionation showing co-purification as a ~100 kDa complex\",\n      \"pmids\": [\"8253090\", \"8253091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the catalytic mechanism or substrate specificity\", \"Stoichiometry and direct biochemical activity not yet characterized\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Connected the ERCC1-XPF complex to the broader NER machinery by demonstrating a direct interaction with the damage-recognition factor XPA.\",\n      \"evidence\": \"XPA affinity column pulldown from HeLa extract plus in vitro complementation\",\n      \"pmids\": [\"8197175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map the interaction interface\", \"Functional consequence of the interaction for incision not established\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Showed the purified heterodimer is itself the endonuclease and is stimulated by RPA, identifying XPF and ERCC4 as the same protein.\",\n      \"evidence\": \"Purification to homogeneity from HeLa and endonuclease assays on model substrates\",\n      \"pmids\": [\"7559382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Polarity and precise cleavage position not yet defined\", \"Which subunit carries the active site unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the structure-specific cleavage rule: incision on the 5' side of ss/ds junctions with a minimal unpaired-nucleotide requirement.\",\n      \"evidence\": \"Recombinant ERCC1-XPF endonuclease assays with systematic substrate variation and divalent cation requirements\",\n      \"pmids\": [\"9525876\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Active-site residues not yet localized\", \"Did not address regulation in cells\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Localized the nuclease active site to XPF residues 670\\u2013740 and separated catalysis from substrate binding.\",\n      \"evidence\": \"Affinity cleavage, site-directed mutagenesis, and parallel nuclease/DNA-binding assays\",\n      \"pmids\": [\"11953324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conformational regulation of the active site not addressed\", \"Role of ERCC1 in catalysis not defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Determined that the complex participates in NER distributively, transiently immobilizing at lesions rather than acting as a preassembled processive machine.\",\n      \"evidence\": \"Live-cell FRAP of GFP-tagged ERCC1/XPF in CHO cells after UV\",\n      \"pmids\": [\"10320375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular trigger of immobilization not defined\", \"Did not address non-NER mobility behavior\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Established at atomic resolution why the ERCC1-XPA interaction is essential for recruiting the complex to NER sites.\",\n      \"evidence\": \"Crystal structure of ERCC1-XPA peptide complex, SPR, and peptide-mediated cell-free NER inhibition\",\n      \"pmids\": [\"17948053\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define recruitment dynamics in living cells\", \"Interface relevance to ICL repair not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Provided the structural basis for asymmetric branched-DNA recognition by the heterodimer's HhH and central domains.\",\n      \"evidence\": \"X-ray crystallography of ERCC1 domains and the XPF-ERCC1 (HhH)\\u2082 heterodimer with ssDNA binding assays, plus archaeal XPF apo/DNA-bound structures\",\n      \"pmids\": [\"16076955\", \"15719018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length complex architecture not resolved\", \"Coupling between DNA binding and catalysis incompletely defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Refined the DNA-recognition model with atomic XPF HhH-ssDNA contacts and demonstrated cooperative, multi-domain DNA binding governs NER versus ICL repair.\",\n      \"evidence\": \"NMR structure of XPF HhH bound to ssDNA and mutagenesis across multiple DNA-binding domains with NER/ICL functional readouts\",\n      \"pmids\": [\"22483113\", \"22547097\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not capture the auto-inhibited full-length conformation\", \"Quantitative affinity differences between pathways not fully mapped\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended the complex's repertoire beyond NER to double-strand break end-joining, single-strand annealing, retrotransposition control, and telomere maintenance.\",\n      \"evidence\": \"Mouse double-mutant genetics and in vitro DSB repair; SSA/gene-conversion reporters; retrotransposition reporters; telomere length and TRF2 ChIP with nuclease-dead mutants\",\n      \"pmids\": [\"18541667\", \"17962301\", \"18396111\", \"18812185\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic step at which XPF acts in each pathway not fully defined\", \"Nuclease-independent telomere role mechanism unresolved\", \"Some readouts from single labs\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed XPF-ERCC1 in recombination intermediate processing via direct interaction with hRad52.\",\n      \"evidence\": \"Co-IP from cell-free extracts plus endonuclease and strand-annealing activity assays\",\n      \"pmids\": [\"14734547\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab without reciprocal in vivo validation\", \"Physiological context of the ternary complex not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Ordered the interstrand crosslink repair pathway: FANCD2 ubiquitylation licenses SLX4/XPF-ERCC1 recruitment for unhooking incisions, with FANCD2 foci themselves requiring upstream unhooking.\",\n      \"evidence\": \"Xenopus egg-extract replication-coupled ICL repair with immunodepletion and FANCD2 ubiquitylation/incision assays; chromatin fractionation and foci counting across species\",\n      \"pmids\": [\"24726325\", \"19805513\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the conformational activation of the nuclease\", \"Spatial positioning of incisions relative to the crosslink not fully resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Dissected ICL repair into separable recruitment, positioning, and catalysis steps and identified RPA and SNM1A as activators/partners of the incision reaction.\",\n      \"evidence\": \"Xenopus extract structure-function mutagenesis of XPF helicase-like and nuclease domains; in vitro RPA-activated incision and SNM1A loading on defined ICL fork substrates\",\n      \"pmids\": [\"28292785\", \"28607004\", \"21896658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo dynamics of the transient XPF-SLX4 interactions not visualized\", \"Regulation of RPA-dependent activation in cells not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified accessory factors and substrate contexts expanding XPF-ERCC1 function to secondary-structure DSBs and stabilization of the SLX4 complex.\",\n      \"evidence\": \"SLX4IP co-IP/GST pulldown with depletion phenotypes; CRISPR/siRNA XPF-FANCM synthetic lethality with HR reporters and G4 drug sensitivity\",\n      \"pmids\": [\"31495888\", \"31153042\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct structural role of SLX4IP unresolved\", \"Single-lab studies without orthogonal confirmation\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed a non-repair function in chromatin organization, showing XPF catalytic activity is required for CTCF-dependent chromatin looping and transcription, later extended to cohesin-dependent imprinted-gene silencing in vivo.\",\n      \"evidence\": \"3C, ChIP, and catalytic-site mutagenesis at RAR\\u03b22; in vivo biotinylation tagging, mass spectrometry, and Ercc1 knockout mouse liver chromatin analysis\",\n      \"pmids\": [\"22771116\", \"28368372\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate cleaved during looping not identified\", \"Generality across other loci incompletely defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected XPF-ERCC1 to R-loop biology through XAB2 association, ALT telomere synthesis, and mis-repair deletions at transcribed loci.\",\n      \"evidence\": \"IP-MS and RNA:DNA hybrid binding with XAB2; TERRA interactome, telomeric XPF ChIP, and ALT readouts; reporter deletion assays with Senataxin/RNaseH1 perturbation and DRIP\",\n      \"pmids\": [\"34039990\", \"36184605\", \"29497062\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct catalytic action on R-loops not biochemically reconstituted\", \"Single-lab studies for several novel functions\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Captured the regulatory switch of the complex: an auto-inhibited DNA-free conformation relieved by junction engagement, and showed FA mutations resist SLX4-dependent activation.\",\n      \"evidence\": \"Cryo-EM of DNA-free and DNA-bound human XPF-ERCC1 with mutagenesis and SLX4-stimulated activation assays\",\n      \"pmids\": [\"32111838\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of the conformational transition in cells not measured\", \"Activation by NER-specific factors not structurally resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established that complex integrity and localization are regulated post-translationally and by heterodimerization, with disease mutations acting through mislocalization.\",\n      \"evidence\": \"USP45 deubiquitylation assays and KO phenotypes; XPF/ERCC1 reciprocal stability and nuclear-import dependence; XFE patient cell mislocalization with nuclear-microinjection rescue\",\n      \"pmids\": [\"25538220\", \"20418188\", \"28130555\", \"20221251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitin ligase opposing USP45 not identified\", \"Import machinery mediating XPF-dependent ERCC1 nuclear entry not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated tissue- and pathway-specific deployment of XPF in NER, with cell type dictating global-genome versus transcription-coupled subpathway usage.\",\n      \"evidence\": \"In vivo imaging of tagged XPF-1 in C. elegans with tissue-specific NER and loss-of-function genetics\",\n      \"pmids\": [\"33440146\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular determinant of subpathway choice not identified\", \"Conservation of tissue specificity in mammals not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse non-canonical roles (chromatin looping, R-loop processing, ALT synthesis) are coordinated with classical repair, and what determines pathway choice at a given substrate, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking conformational activation to non-repair substrate engagement\", \"Regulatory hierarchy among partners (SLX4, XAB2, CTCF, USP45) not integrated\", \"Substrates cleaved during transcriptional/looping functions not biochemically defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [2, 3, 5]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [2, 3, 5]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [8, 20, 5]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [31, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 16, 30]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [13, 26, 33]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1, 3, 14, 22]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [18, 26]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [16, 21, 36]}\n    ],\n    \"complexes\": [\n      \"ERCC1-XPF heterodimer\",\n      \"SLX4-XPF-ERCC1 complex\",\n      \"XAB2-ERCC1-XPF-XPG complex\"\n    ],\n    \"partners\": [\n      \"ERCC1\",\n      \"XPA\",\n      \"SLX4\",\n      \"RPA\",\n      \"USP45\",\n      \"SLX4IP\",\n      \"RAD52\",\n      \"XAB2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":8,"faith_total":8,"faith_pct":100.0}}